Cargando…

Outpatient parenteral antimicrobial therapy with ceftriaxone for acute tonsillopharyngitis: efficacy, patient satisfaction, cost effectiveness, and safety

BACKGROUND: Outpatient parenteral antimicrobial therapy (OPAT) is the administration of intravenous antimicrobial therapy to patients in an outpatient setting. It may be used for patients who have infections that require parenteral treatment but who are otherwise stable enough to not require admissi...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Alawi, Samah, Abdulkarim, Somaya, Elhennawy, Hazem, Al-Mansoor, Anwar, Al Ansari, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536842/
https://www.ncbi.nlm.nih.gov/pubmed/26300650
http://dx.doi.org/10.2147/IDR.S86341
_version_ 1782385806925627392
author Al Alawi, Samah
Abdulkarim, Somaya
Elhennawy, Hazem
Al-Mansoor, Anwar
Al Ansari, Ahmed
author_facet Al Alawi, Samah
Abdulkarim, Somaya
Elhennawy, Hazem
Al-Mansoor, Anwar
Al Ansari, Ahmed
author_sort Al Alawi, Samah
collection PubMed
description BACKGROUND: Outpatient parenteral antimicrobial therapy (OPAT) is the administration of intravenous antimicrobial therapy to patients in an outpatient setting. It may be used for patients who have infections that require parenteral treatment but who are otherwise stable enough to not require admission as inpatients. OBJECTIVE: We aimed to review the treatment of patients with acute tonsillopharyngitis at the OPAT health care clinic in the Bahrain Defense Force Royal Medical Services (BDF-RMS), with regard to efficacy, patient satisfaction, cost effectiveness, and safety. METHODS: A retrospective case notes review was conducted for all patients admitted to the OPAT clinic in the BDF-RMS with acute tonsillopharyngitis treated with ceftriaxone, between March 2012 and March 2014. RESULTS: In the period between March 2012 and March 2014, 97 patients with acute tonsillopharyngitis were treated with ceftriaxone for a minimum of 3 days at the OPAT clinic. In total, 94.8% of patients completed the prescribed course of ceftriaxone. Total cure was achieved in 89.7% of patients. Usage of the OPAT clinic led to cost savings of 10,693 BD, while total bed days saved were 301 over the 2-year period examined by this study. Participants in the program expressed high satisfaction rates, and the average (± standard deviation) score on a patient satisfaction survey was 4.41 (± 0.31) out of a total of 5. This study highlights the efficacy, patient satisfaction, cost effectiveness, and safety of the OPAT clinic service for the treatment of acute tonsillopharyngitis with ceftriaxone. We found a 45.5% drop in admission rate for acute tonsillopharyngitis after starting the OPAT service clinic and that 301 bed days were saved through this treatment. CONCLUSION: This study showed that the management of acute tonsillopharyngitis with ceftriaxone in the OPAT clinic is safe, clinically effective, and cost effective, with low rates of complications/readmissions and high levels of patient satisfaction.
format Online
Article
Text
id pubmed-4536842
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-45368422015-08-21 Outpatient parenteral antimicrobial therapy with ceftriaxone for acute tonsillopharyngitis: efficacy, patient satisfaction, cost effectiveness, and safety Al Alawi, Samah Abdulkarim, Somaya Elhennawy, Hazem Al-Mansoor, Anwar Al Ansari, Ahmed Infect Drug Resist Original Research BACKGROUND: Outpatient parenteral antimicrobial therapy (OPAT) is the administration of intravenous antimicrobial therapy to patients in an outpatient setting. It may be used for patients who have infections that require parenteral treatment but who are otherwise stable enough to not require admission as inpatients. OBJECTIVE: We aimed to review the treatment of patients with acute tonsillopharyngitis at the OPAT health care clinic in the Bahrain Defense Force Royal Medical Services (BDF-RMS), with regard to efficacy, patient satisfaction, cost effectiveness, and safety. METHODS: A retrospective case notes review was conducted for all patients admitted to the OPAT clinic in the BDF-RMS with acute tonsillopharyngitis treated with ceftriaxone, between March 2012 and March 2014. RESULTS: In the period between March 2012 and March 2014, 97 patients with acute tonsillopharyngitis were treated with ceftriaxone for a minimum of 3 days at the OPAT clinic. In total, 94.8% of patients completed the prescribed course of ceftriaxone. Total cure was achieved in 89.7% of patients. Usage of the OPAT clinic led to cost savings of 10,693 BD, while total bed days saved were 301 over the 2-year period examined by this study. Participants in the program expressed high satisfaction rates, and the average (± standard deviation) score on a patient satisfaction survey was 4.41 (± 0.31) out of a total of 5. This study highlights the efficacy, patient satisfaction, cost effectiveness, and safety of the OPAT clinic service for the treatment of acute tonsillopharyngitis with ceftriaxone. We found a 45.5% drop in admission rate for acute tonsillopharyngitis after starting the OPAT service clinic and that 301 bed days were saved through this treatment. CONCLUSION: This study showed that the management of acute tonsillopharyngitis with ceftriaxone in the OPAT clinic is safe, clinically effective, and cost effective, with low rates of complications/readmissions and high levels of patient satisfaction. Dove Medical Press 2015-08-07 /pmc/articles/PMC4536842/ /pubmed/26300650 http://dx.doi.org/10.2147/IDR.S86341 Text en © 2015 Al Alawi et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Al Alawi, Samah
Abdulkarim, Somaya
Elhennawy, Hazem
Al-Mansoor, Anwar
Al Ansari, Ahmed
Outpatient parenteral antimicrobial therapy with ceftriaxone for acute tonsillopharyngitis: efficacy, patient satisfaction, cost effectiveness, and safety
title Outpatient parenteral antimicrobial therapy with ceftriaxone for acute tonsillopharyngitis: efficacy, patient satisfaction, cost effectiveness, and safety
title_full Outpatient parenteral antimicrobial therapy with ceftriaxone for acute tonsillopharyngitis: efficacy, patient satisfaction, cost effectiveness, and safety
title_fullStr Outpatient parenteral antimicrobial therapy with ceftriaxone for acute tonsillopharyngitis: efficacy, patient satisfaction, cost effectiveness, and safety
title_full_unstemmed Outpatient parenteral antimicrobial therapy with ceftriaxone for acute tonsillopharyngitis: efficacy, patient satisfaction, cost effectiveness, and safety
title_short Outpatient parenteral antimicrobial therapy with ceftriaxone for acute tonsillopharyngitis: efficacy, patient satisfaction, cost effectiveness, and safety
title_sort outpatient parenteral antimicrobial therapy with ceftriaxone for acute tonsillopharyngitis: efficacy, patient satisfaction, cost effectiveness, and safety
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4536842/
https://www.ncbi.nlm.nih.gov/pubmed/26300650
http://dx.doi.org/10.2147/IDR.S86341
work_keys_str_mv AT alalawisamah outpatientparenteralantimicrobialtherapywithceftriaxoneforacutetonsillopharyngitisefficacypatientsatisfactioncosteffectivenessandsafety
AT abdulkarimsomaya outpatientparenteralantimicrobialtherapywithceftriaxoneforacutetonsillopharyngitisefficacypatientsatisfactioncosteffectivenessandsafety
AT elhennawyhazem outpatientparenteralantimicrobialtherapywithceftriaxoneforacutetonsillopharyngitisefficacypatientsatisfactioncosteffectivenessandsafety
AT almansooranwar outpatientparenteralantimicrobialtherapywithceftriaxoneforacutetonsillopharyngitisefficacypatientsatisfactioncosteffectivenessandsafety
AT alansariahmed outpatientparenteralantimicrobialtherapywithceftriaxoneforacutetonsillopharyngitisefficacypatientsatisfactioncosteffectivenessandsafety